<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma</title>
	<atom:link href="http://www.mesothelioma-line.com/articles/2005/04/11/second-line-post-study-chemotherapy-received-by-patients-treated-in-the-phase-iii-trial-of-pemetrexed-plus-cisplatin-versus-cisplatin-alone-in-malignant-pleural-mesothelioma/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.mesothelioma-line.com/articles/2005/04/11/second-line-post-study-chemotherapy-received-by-patients-treated-in-the-phase-iii-trial-of-pemetrexed-plus-cisplatin-versus-cisplatin-alone-in-malignant-pleural-mesothelioma/</link>
	<description>Journal Articles on Mesothelioma: Cancer Information for Patients and Families</description>
	<pubDate>Tue, 06 Jan 2009 15:32:33 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
